TCG Labs-Soleil
Maryam Bhatti is a seasoned scientist with extensive experience in protein engineering and biologics development. Currently working as a Scientist II at Soleil Labs since November 2023, Maryam previously held multiple roles at Atreca, Inc. from January 2019 to November 2023, where responsibilities included leading a pipeline team on various antibody projects and training research associates. Prior experience includes roles at Iconic Therapeutics, Inc. focusing on biologics for oncology and ophthalmology, and earlier positions involved product development and research tasks in various laboratories. Maryam holds a Master’s Degree in Biotechnology from San Francisco State University and a B.S. in Chemical Engineering from the University of California, Davis.
TCG Labs-Soleil
At TCG Labs-Soleil, we are establishing a pioneering venture-biotech model in collaboration with The Column Group. Our mission is to efficiently translate scientific insights into therapeutic solutions for patients facing serious diseases. Our approach integrates a dedicated venture fund (TCG Labs) with an evergreen R&D hub led by top-tier scientists (Soleil). This creates a powerful ecosystem forming and overseeing independent portfolio companies, each dedicated to single-asset biologic programs, guiding them from ideation to clinical proof of concept and positioning them for strategic partnerships and transformative medical advancements.